Effect of Synaid on cognitive functions and mood in elderly subjects with self-perceived loss of memory after COVID-19 infection

Marilisa Bove; Federica Fogacci; Silvia Quattrocchi; Maddalena Veronesi; Arrigo F G Cicero

doi:10.5114/aoms/141502

Effect of Synaid on cognitive functions and mood in elderly subjects with self-perceived loss of memory after COVID-19 infection

Arch Med Sci. 2021 Sep 17;17(6):1797-1799. doi: 10.5114/aoms/141502. eCollection 2021.

Authors

Marilisa Bove¹, Federica Fogacci², Silvia Quattrocchi¹, Maddalena Veronesi¹, Arrigo F G Cicero²

Affiliations

¹ IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
² Medical and Surgical Sciences Department, University of Bologna, Bologna, Italy.

Abstract

Introduction: There is growing attention towards the possible long-term effect of COVID-19 on neuropsychiatric disorders.

Methods: We tested the effect of a combined nutraceutical (Synaid) with known nootropic effects in 40 elderly patients with self-perceived cognitive decline after SARS-CoV-2 infection, treated at home or in hospital.

Results: After 3 months of treatment, Synaid significantly improved functional status, MMSE and the main psychological disorders associated with mild cognitive impairment, both in patients previously cared for at home and in hospital because of SARS-CoV-2 infection.

Conclusions: Synaid was well tolerated and effective in improving cognitive function and psychosocial parameters after SARS-CoV-2 infection.

Keywords: COVID-19; cognitive function; dietary supplement; nutraceutical.